SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant retail and institutional interest as investors anticipate major clinical milestones, specifically the upcoming pancreatic cancer data and U.S. trial recruitment results. The community remains highly bullish, frequently discussing the company's strong balance sheet, the potential of its Alpha DaRT platform, and the recent positive analyst sentiment that highlights significant upside from current levels.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently experiencing significant momentum as investors anticipate the upcoming launch of its BlueBird 7 satellite, a pivotal milestone in its efforts to provide direct-to-device cellular broadband. Community sentiment is overwhelmingly bullish, with discussions focused on potential strategic partnerships with tech giants, the scaling of satellite deployment, and the broader institutional shift toward space-based infrastructure as a critical sector for future connectivity.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing a surge in momentum and heightened community focus following a series of strategic catalysts, including a multi-year partnership with Anthropic and an expanded compute deal with Meta. Traders are actively debating the stock's potential for a short squeeze as institutional capital flows into AI infrastructure, with many participants viewing the firm as a critical player in the compute arms race.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing a significant shift in sentiment as investors pivot from pure-play Bitcoin mining to the company's massive 1.4GW high-performance computing expansion. The community is actively debating the impact of the company's capital strategy and potential upcoming deal flow, while traders closely monitor the stock's technical recovery from recent lows amid the broader AI infrastructure demand cycle.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors react to a powerful streak of positive news, including high-profile partnerships with major hyperscalers and renewed confidence in its foundry strategy. The community is actively debating whether this rapid valuation increase represents a legitimate long-term turnaround or an overextended momentum play, with many traders closely monitoring institutional flow and price action ahead of upcoming earnings.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is under significant pressure as the weight-loss drug market becomes increasingly competitive with new oral offerings from Eli Lilly, driving concerns about long-term market share and pricing power. While investors remain divided on whether the stock is a deep-value opportunity given its current valuation and pipeline potential, community sentiment is largely frustrated by the stock's persistent downward trend and lack of bullish momentum.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a surge in retail interest and bullish sentiment as traders analyze the company's strategic positioning within the AI infrastructure stack and speculate on its role in critical data center supply chains. Community discussion is heavily focused on the company's substantial cash-to-value ratio, potential acquisition interest, and the high-conviction bet that its proprietary optical interposer technology will solve major bandwidth bottlenecks for hyperscalers.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending due to its $750 million acquisition of DustPhotonics, a strategic move designed to dominate the silicon photonics market and accelerate its expansion into next-generation AI infrastructure. Investors are actively discussing the company's dual-track expertise in copper and optical connectivity, with many highlighting the stock as a key 'picks and shovels' play in the burgeoning AI data center sector.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in conversation as the community highlights its status as the original Bitcoin parody from 2011, currently re-emerging on-chain with backing from original creators and whale accumulation. Investors are debating its long-term viability as a cultural artifact versus its nature as a high-risk speculative asset, with many pointing to its 15-year history as a key differentiator from newer meme coins.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is currently trending due to its recent $4M+ in U.S. government contract wins and the strategic hiring of industry veterans to accelerate its transition from R&D to commercial-scale production. The investment community is intensely focused on the company's progress in wafer-scale semiconductor integration, with significant debate over its potential to supply next-generation sensors for consumer mobile devices and data center optical interconnects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Talphera (NASDAQ:TLPH) CEO Acquires $125,852.90 in Stock

Talphera, Inc. (NASDAQ:TLPH - Get Free Report) CEO Vincent Angotti purchased 213,310 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average price of $0.59 per share, with a total value of $125,852.90. Following the purchase, the chief...

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 PR Newswire SAN MATEO, Calif., March 25...

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate...

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 Talphera to Host Virtual Investor & Analyst Event to...

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial PR Newswire SAN MATEO...

Insider Buying: Talphera (NASDAQ:TLPH) CEO Buys 105,364 Shares of Stock

Talphera, Inc. (NASDAQ:TLPH - Get Free Report) CEO Vincent Angotti acquired 105,364 shares of the business's stock in a transaction that occurred on Thursday, February 12th. The stock was bought at...

Talphera (NASDAQ:TLPH) Stock Price Down 2.7% - Here's Why

Talphera (NASDAQ:TLPH) Stock Price Down 2.7% - Here's What Happened...

Talphera (NASDAQ:TLPH) Trading 3.2% Higher - Here's Why

Talphera (NASDAQ:TLPH) Shares Up 3.2% - Here's What Happened...

Talphera (NASDAQ:TLPH) Releases Earnings Results, Beats Estimates By $0.01 EPS

Talphera (NASDAQ:TLPH - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.01...

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes Nafamostat, LTX-608, and Niyad. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Talphera Inc.

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

TLPH
Acelrx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TLPH News

TLPHAcelrx Pharmaceuticals Inc